Supply of TruDose BG Devices (Without Telemetry Remote Monitoring)

The contract involves the supply of 13 commercial off-the-shelf TruDose BG blood glucose monitoring devices specifically designed for visually impaired users, ensuring accessibility and usability without telemetry or remote monitoring capabilities. These devices must fully comply with both FDA regulations and Department of Defense marking standards to meet operational and safety requirements. The procurement is structured as a subcontract under the Defense Logistics Agency, which operates under the Department of Defense, and is classified under NAICS code 334510 for medical device manufacturing. Though no specific delivery location or point of contact is detailed, the award is linked to the DIBBS system with a reference to the contract SPS8EZ21D0003 and delivery order SPE8EJ26F070G, indicating it is part of an existing defense acquisition framework. The posting date of August 3, 2026, suggests this is a future-bound procurement, likely pre-allocated for anticipated needs within the military healthcare system.